Announcements Trials
Browse Landscape

Phase

Phase NA 104Phase 2 16Phase 3 11Phase 1 6Phase EARLY_PHASE1 2Phase 2/3 2Phase 1/2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Breast 1

Conditions

Hematologic Neoplasms 1COVID-19 1Breast Neoplasms 1

Interventions

pembrolizumab 212Cyclophosphamide 120Nivolumab 110Carboplatin 92fludarabine 79Gemcitabine 79Specimen Handling 74Bevacizumab 73venetoclax 70Injections 70Magnetic Resonance Spectroscopy 68Paclitaxel 66Dexamethasone 66Biopsy 59atezolizumab 56Cisplatin 54Ipilimumab 49Temozolomide 45Lenalidomide 43Docetaxel 43Azacitidine 43Pemetrexed 42Rituximab 41Oxaliplatin 40Fluorouracil 40Radiotherapy 39Cetuximab 39durvalumab 37Cytarabine 36Capecitabine 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Practice Guidelines as Topic × 1 year × Clear all
NCT04565665 2026-05-20

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
65 enrolled
Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT06502691 2026-05-19

[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer

University of Washington

Phase 1/2 Recruiting
22 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡